TITLE:
Study of Botulinum Toxin in Patients With Primary Hyperhidrosis

CONDITION:
Hyperhidrosis

INTERVENTION:
botulinum toxin type A

SUMMARY:

      OBJECTIVES:

      I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients
      with primary hyperhidrosis.
    

DETAILED DESCRIPTION:

      PROTOCOL OUTLINE:

      Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients
      undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of
      the drug. Patients also complete questionnaires to evaluate the amount of sweating.
    

ELIGIBILITY:
Gender: All
Age: 16 Years to N/A
Criteria:

        -  Diagnosis of hyperhidrosis

          -  Excessive sweating in the hands, feet, armpits, forehead, or body
      
